Related Experiment Video
Updated: Nov 3, 2025
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
[Global Trends in Pre-clinical Research on Malignant Glioma]
1Department of Neurosurgery, School of Medicine, University of Alabama at Birmingham.
Abstract:
Finding novel treatment approaches for brain tumors is challenging, especially for malignant gliomas. A wealth of genetic and expression data on malignant glioma has accumulated in recent years; however, therapies targeting the underlying oncogenic pathways have not succeeded in substantially improving therapeutic responses or survival, owning to tumor resistance mechanisms to these therapies. Therefore, new therapeutic approaches are necessary to reduce the mortality rates in patients with glioma. This study examined current trends in preclinical research for malignant glioma to predict future therapies. This analysis revealed that current preclinical research mainly focused on the immune response and tumor microenvironment. Knowledge from these researches may lead to the development of new therapeutics for the management of malignant glioma.
Insights
New research trends in malignant glioma preclinical studies focus on the immune response and tumor microenvironment. This knowledge may lead to novel therapies for brain tumors, improving patient outcomes.
Area of Science:
- Neuro-oncology
- Cancer Research
- Immunotherapy
Background:
- Malignant gliomas present significant therapeutic challenges due to inherent resistance mechanisms.
- Despite extensive genetic data, current therapies targeting oncogenic pathways offer limited survival benefits for glioma patients.
- Novel treatment strategies are urgently needed to improve outcomes for malignant glioma.
Purpose of the Study:
- To analyze current trends in preclinical research for malignant glioma.
- To identify emerging research areas that may inform future therapeutic development.
- To predict the direction of novel therapies for glioma treatment.
Main Methods:
- Systematic review of recent preclinical research on malignant glioma.
- Trend analysis focusing on research themes and investigated pathways.
- Identification of key areas of focus in current glioma research.
Main Results:
- Preclinical research predominantly concentrates on the tumor microenvironment.
- Significant focus is placed on understanding and manipulating the immune response within gliomas.
- Emerging research highlights the interplay between the tumor and its surrounding environment.
Conclusions:
- Future glioma therapies are likely to leverage immunomodulatory strategies.
- Targeting the tumor microenvironment holds promise for overcoming treatment resistance.
- Advances in understanding glioma's immune landscape may yield more effective treatments.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019